Intermediate (Shanghai) Industrial Development Co., Ltd., as a leading global supplier of pharmaceutical intermediates and innovative chemicals, recently announced strategic partnerships with multiple domestic and international partners to further expand its business layout in the global pharmaceutical intermediates market. This cooperation will effectively promote the competitiveness of Intermediate in the global market and inject strong impetus into the company's future development. In the context of globalization, Intermediate has always adhered to technological innovation as the driving force and actively expanded its international market. Through close cooperation with well-known research institutions, pharmaceutical manufacturers, and distributors at home and abroad, Intermediate's products have gradually covered multiple regions such as Europe, America, Asia Pacific, and Latin America. Through joint research and development, product sharing, and technical support, Intermediate will promote innovation and production of pharmaceutical intermediates, providing global pharmaceutical companies with more stable, high-quality, and customized intermediate products.
Strengthen technological innovation and enhance product competitiveness
With the increasing demand for high-quality and intermediate products in the global pharmaceutical industry, Intermediate actively responds to market demand, continuously optimizes product structure through continuous technological innovation, and enhances product added value. The company has established a strong research and development base in the Yangtze River Delta region, dedicated to the research and development of high-end pharmaceutical intermediates. By sharing the latest technological achievements with international partners, Intermediate has further enhanced its research and development capabilities in the field of pharmaceutical intermediates, ensuring that it can meet the increasingly complex needs of the global pharmaceutical industry. Intermediate is well aware that the demands of different regions and markets vary, and customers' requirements for pharmaceutical intermediates are increasingly becoming personalized and customized. Therefore, the company places special emphasis on product customization services, providing tailored solutions to meet the specific needs of customers worldwide. Whether it's optimizing the formula of pharmaceutical intermediates, improving production processes, or supplying products that meet specific quality standards, Intermediate can provide customers with comprehensive technical support and personalized services.
While promoting the expansion of the pharmaceutical intermediate market, Intermediate has always adhered to the concept of green development and is committed to the research and production of environmentally friendly chemicals. The company has strengthened cooperation with international leading environmental technology enterprises, promoted the application of green chemical processes, reduced energy consumption and environmental pollution in the production process, and strived to achieve a win-win situation of economic and social benefits. Intermediate stated that it will continue to strengthen strategic cooperation with domestic and foreign partners in the future, and further consolidate its leading position in the global pharmaceutical intermediate market through technological innovation and market expansion. The company will continuously improve product quality and service level, providing global customers with more efficient, environmentally friendly, and competitive pharmaceutical intermediate solutions.
The achievement of this strategic cooperation is an important step for Intermediate to deepen its global market layout, and also marks the acceleration of the company's internationalization process in the field of pharmaceutical intermediates. Intermediate will continue to drive global business expansion and strive to become a leader in the global pharmaceutical intermediate field, contributing to the innovation and development of the global pharmaceutical industry.
